| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GNLX | GENELUX Corp | John W. Smither | Director | Sep 13, 2023 | Sale | $20.78 | 900 | 18,702 | 6,920 | Sep 14, 2023, 08:18 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Mar 10, 2021 | Option/RSU Exercise | $1.68 | 500 | 840 | 46,821 | Mar 11, 2021, 03:59 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Mar 10, 2021 | Sale | $32.90 | 500 | 16,450 | 46,321 | Mar 11, 2021, 03:59 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Mar 10, 2021 | Sale | $32.90 | 1,250 | 41,125 | 86,715 | Mar 11, 2021, 03:59 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Mar 04, 2021 | Option/RSU Exercise | $1.68 | 12,396 | 20,833 | 46,321 | Mar 05, 2021, 03:55 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Mar 01, 2021 | Sale | $34.20 | 773 | 26,440 | 24,425 | Mar 03, 2021, 04:48 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Feb 10, 2021 | Option/RSU Exercise | $1.68 | 750 | 1,260 | 25,948 | Feb 12, 2021, 05:32 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Feb 10, 2021 | Sale | $35.64 | 750 | 26,730 | 25,198 | Feb 12, 2021, 05:32 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Feb 10, 2021 | Sale | $35.64 | 2,000 | 71,280 | 87,965 | Feb 12, 2021, 05:32 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Feb 01, 2021 | Sale | $35.00 | 3,750 | 131,250 | 89,965 | Feb 03, 2021, 11:23 AM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Feb 01, 2021 | Option/RSU Exercise | $1.68 | 1,250 | 2,101 | 26,448 | Feb 03, 2021, 11:23 AM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Feb 01, 2021 | Sale | $35.00 | 1,250 | 43,750 | 25,198 | Feb 03, 2021, 11:23 AM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Jan 19, 2021 | Option/RSU Exercise | $1.68 | 500 | 840 | 25,698 | Jan 21, 2021, 04:41 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Jan 19, 2021 | Sale | $30.00 | 500 | 15,000 | 25,198 | Jan 21, 2021, 04:41 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Jan 19, 2021 | Sale | $30.00 | 1,250 | 37,500 | 93,715 | Jan 21, 2021, 04:41 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Dec 14, 2020 | Sale | $30.00 | 3,750 | 112,500 | 94,965 | Dec 16, 2020, 03:14 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Dec 14, 2020 | Option/RSU Exercise | $1.68 | 1,500 | 2,521 | 26,698 | Dec 16, 2020, 03:14 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Dec 14, 2020 | Sale | $30.00 | 1,500 | 45,000 | 25,198 | Dec 16, 2020, 03:14 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Sep 29, 2020 | Option/RSU Exercise | $1.68 | 500 | 840 | 24,375 | Oct 01, 2020, 09:00 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Sep 29, 2020 | Sale | $30.00 | 500 | 15,000 | 23,875 | Oct 01, 2020, 09:00 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Sep 29, 2020 | Sale | $30.00 | 1,250 | 37,500 | 98,715 | Oct 01, 2020, 09:00 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | John W. Smither | Chief Financial Officer | Jun 11, 2020 | Option/RSU Exercise | $1.68 | 14,875 | 24,999 | 123,840 | Jun 15, 2020, 03:15 PM |